CAS No.:108-46-3
Name: Resorcinol
Details Introduction
TOXICITY DATA with REFERENCE:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LDLo | subcutaneous | 110mg/kg (110mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BLOOD: METHEMOGLOBINEMIA-CARBOXYHEMOGLOBIN |
Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 72, Pg. 241, 1913. |
dog | LDLo | intravenous | 700mg/kg (700mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1289, 1935. | |
frog | LDLo | parenteral | 270mg/kg (270mg/kg) | PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE CARDIAC: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 166, Pg. 437, 1932. |
guinea pig | LDLo | subcutaneous | 400mg/kg (400mg/kg) | BEHAVIORAL: EXCITEMENT BEHAVIORAL: TETANY BEHAVIORAL: COMA |
Revue Medicale de la Suisse Romande. Vol. 15, Pg. 561, 1895. |
human | LDLo | oral | 29mg/kg (29mg/kg) | "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 519, 1969. | |
mouse | LD50 | intraperitoneal | 215mg/kg (215mg/kg) | Bulletin of Experimental Biology and Medicine Vol. 61, Pg. 291, 1966. | |
mouse | LD50 | oral | 200mg/kg (200mg/kg) | Japanese Journal of Toxicology. Vol. 4, Pg. 105, 1991. | |
mouse | LD50 | subcutaneous | 213mg/kg (213mg/kg) | Zeitschrift fuer die Gesamte Innere Medizin und Ihre Grenzgebiete. Vol. 2, Pg. 333, 1947. | |
rabbit | LD50 | skin | 3360mg/kg (3360mg/kg) | SKIN AND APPENDAGES (SKIN): PRIMARY IRRITATION: AFTER TOPICAL EXPOSURE | American Industrial Hygiene Association Journal. Vol. 37, Pg. 596, 1976. |
rat | LCLo | inhalation | 160mg/m3/1H (160mg/m3) | BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. Vol. 11-4/1970, | |
rat | LD50 | oral | 301mg/kg (301mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
BIOFAX Industrial Bio-Test Laboratories, Inc., Data Sheets. Vol. 11-4/1970, |
rat | LDLo | subcutaneous | 400mg/kg (400mg/kg) | BEHAVIORAL: EXCITEMENT BEHAVIORAL: TETANY BEHAVIORAL: COMA |
Revue Medicale de la Suisse Romande. Vol. 15, Pg. 561, 1895. |
Consensus Reports:
SAFETY PROFILE:
Hazard Codes: Xn,
N
Risk Statements:
22: Harmful if swallowed
50: Very Toxic to aquatic organisms
36/38: Irritating to eyes and skin
Safety Statements:
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
61: Avoid release to the environment. Refer to special instructions safety data sheet
Standards and Recommendations:
Analytical Methods:
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione